6/3/2023 0 Comments Marigor und die tobishimaTo this end, we have been proactively engaged in R&D activities to contribute to the improvement of the quality of life(QOL)of patients: in the former area, to create innovative and more effective pharmaceuticals to ease their pain caused by invasive operation or realize successful management of their pain associated with disease in the latter area, to create products that provide the optimal hygienic environment for medical professionals and patients. In recent years, we have focused on two specific areas−perioperative drugs and disinfectants/antiseptics, aiming for a more advanced“Specialty Pharma”with a strong presence in these areas. Long ago in 1888, the year following the issuance of the first Japanese Pharmacopoeia, we started our business as a manufacturer of essential drugs listed in Japanese Pharmacopoeia.Since then, based on our solid management policy, we have continuously striven to contribute to the betterment of healthcare and enhance people's health and welfare through our enthusiastic business activities, covering R&D, manufacturing and marketing. Maruishi Pharmaceutical Co.,Ltd.|About Maruishi|Message from Management.
0 Comments
Leave a Reply. |